Cargando…

Dexamethasone suppresses immune evasion by inducing GR/STAT3 mediated downregulation of PD-L1 and IDO1 pathways

T cell exhaustion plays critical roles in tumor immune evasion. Novel strategies to suppress immune evasion are in urgent need. We aimed to identify potential compounds to target T cell exhaustion and increase response to immune checkpoint inhibitors (ICIs). Differentially expressed genes (DEGs) wer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiang, Zhen, Zhou, Zhijun, Song, Shuzheng, Li, Jun, Ji, Jun, Yan, Ranlin, Wang, Jiexuan, Cai, Wei, Hu, Wenjun, Zang, Lu, Zhu, Zhenggang, Zhang, Zhen, Li, Min, Yu, Yingyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235907/ https://www.ncbi.nlm.nih.gov/pubmed/34175886 http://dx.doi.org/10.1038/s41388-021-01897-0

Ejemplares similares

A positive feedback between IDO1 metabolite and COL12A1 via MAPK pathway to promote gastric cancer metastasis
por: Xiang, Zhen, et al.
Publicado: (2019)

A Novel Citrullinated Modification of Histone 3 and Its Regulatory Mechanisms Related to IPO-38 Antibody-Labeled Protein
por: Song, Shuzheng, et al.
Publicado: (2019)

Cross-Database Analysis Reveals Sensitive Biomarkers for Combined Therapy for ERBB2+ Gastric Cancer
por: Xiang, Zhen, et al.
Publicado: (2018)

Genetic Profiles Affect the Biological Effects of Serine on Gastric Cancer Cells
por: Li, Jun, et al.
Publicado: (2020)

The Anticancer Effects of Atractylenolide III Associate With the Downregulation of Jak3/Stat3-Dependent IDO Expression
por: Liu, Jun-bao, et al.
Publicado: (2020)

LncRNAs GIHCG and SPINT1-AS1 Are Crucial Factors for Pan-Cancer Cells Sensitivity to Lapatinib
por: Xiang, Zhen, et al.
Publicado: (2019)

Glucocorticoids improve severe or critical COVID-19 by activating ACE2 and reducing IL-6 levels
por: Xiang, Zhen, et al.
Publicado: (2020)

Tracking cancer lesions on surgical samples of gastric cancer by artificial intelligent algorithms
por: Yang, Ruixin, et al.
Publicado: (2021)

A quick and reliable image-based AI algorithm for evaluating cellular senescence of gastric organoids
por: Yang, Ruixin, et al.
Publicado: (2023)

LncRNA XIST promotes inflammation by downregulating GRα expression in the adenoids of children with OSAHS
por: Zhou, Zhen, et al.
Publicado: (2021)

Impact of IDO1 and IDO2 on the B Cell Immune Response
por: Merlo, Lauren M. F., et al.
Publicado: (2022)

LysGR1, a novel thermostable endolysin from Geobacillus stearothermophilus bacteriophage GR1
por: Choi, Dahee, et al.
Publicado: (2023)

Amyloid β neurotoxicity is IDO1–Kyn–AhR dependent and blocked by IDO1 inhibitor
por: Duan, Zhenzhen, et al.
Publicado: (2020)

Differential Roles of IDO1 and IDO2 in T and B Cell Inflammatory Immune Responses
por: Merlo, Lauren M. F., et al.
Publicado: (2020)

GR Dimerization and the Impact of GR Dimerization on GR Protein Stability and Half-Life
por: Louw, Ann
Publicado: (2019)

Targeting the STAT5A/IDO1 axis overcomes radioresistance and reverses the immunosuppressive tumor microenvironment in NSCLC
por: Yang, Yang, et al.
Publicado: (2022)

Machine learning reveals STAT motifs as predictors for GR-mediated gene repression
por: Höllbacher, Barbara, et al.
Publicado: (2023)

Synthesis and Biological Evaluation of Novel 2-Amino-1,4-Naphthoquinone Amide-Oxime Derivatives as Potent IDO1/STAT3 Dual Inhibitors with Prospective Antitumor Effects
por: Huang, Ri-Zhen, et al.
Publicado: (2023)

Genetic Polymorphisms Affecting IDO1 or IDO2 Activity Differently Associate With Aspergillosis in Humans
por: Napolioni, Valerio, et al.
Publicado: (2019)

Tolerogenic IDO(+) Dendritic Cells Are Induced by PD-1-Expressing Mast Cells
por: Rodrigues, Cecilia Pessoa, et al.
Publicado: (2016)

Progression on Citrullination of Proteins in Gastrointestinal Cancers
por: Song, Shuzheng, et al.
Publicado: (2019)

Discovery of Icotinib-1,2,3-Triazole Derivatives as IDO1 Inhibitors
por: Mao, Long-fei, et al.
Publicado: (2020)

Interaction of Glucocorticoid Receptor (GR) with Estrogen Receptor (ER) α and Activator Protein 1 (AP1) in Dexamethasone-mediated Interference of ERα Activity
por: Karmakar, Sudipan, et al.
Publicado: (2013)

Indoleamine 2,3‐dioxygenase (IDO)‐1 and IDO‐2 activity and severe course of COVID‐19
por: Guo, Lihui, et al.
Publicado: (2022)

Muscle-specific downregulation of GR levels inhibits adipogenesis in porcine intramuscular adipocyte tissue
por: Chu, Weiwei, et al.
Publicado: (2017)

High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer Patients
por: Ludovini, Vienna, et al.
Publicado: (2021)

Oxaliplatin-Resistant Hepatocellular Carcinoma Drives Immune Evasion Through PD-L1 Up-Regulation and PMN-Singular Recruitment
por: Zhang, Feng, et al.
Publicado: (2022)

Immunological Relevance of the Coevolution of IDO1 and AHR
por: Jaronen, Merja, et al.
Publicado: (2014)

IDO1 is an Integral Mediator of Inflammatory Neovascularization
por: Mondal, Arpita, et al.
Publicado: (2016)

The Indoleamine-2,3-Dioxygenase (IDO) Inhibitor 1-Methyl-D-tryptophan Upregulates IDO1 in Human Cancer Cells
por: Opitz, Christiane A., et al.
Publicado: (2011)

IL-27 induces the expression of IDO and PD-L1 in human cancer cells
por: Carbotti, Grazia, et al.
Publicado: (2015)

Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC?
por: Botticelli, Andrea, et al.
Publicado: (2018)

Revisiting IDO and its value as a predictive marker for anti-PD-1 resistance
por: Moon, Peter Kim, et al.
Publicado: (2019)

Hemophagocytic Lymphohistiocytosis Secondary to PD-1 and IDO Inhibition in a Patient with Refractory Glioblastoma
por: Thummalapalli, Rohit, et al.
Publicado: (2020)

Dietary betaine activates hepatic VTGII expression in laying hens associated with hypomethylation of GR gene promoter and enhanced GR expression
por: Omer, Nagmeldin A., et al.
Publicado: (2018)

Superinduction of immunosuppressive glioblastoma extracellular vesicles by IFN-γ through PD-L1 and IDO1
por: Jung, Mi-Yeon, et al.
Publicado: (2022)

Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC
por: Della Corte, Carminia Maria, et al.
Publicado: (2022)

Hepatotoxicity in patients with solid tumors treated with PD-1/PD-L1 inhibitors alone, PD-1/PD-L1 inhibitors plus chemotherapy, or chemotherapy alone: systematic review and meta-analysis
por: Guo, Xiaodi, et al.
Publicado: (2020)

IDO1 and IDO2 Non-Synonymous Gene Variants: Correlation with Crohn's Disease Risk and Clinical Phenotype
por: Lee, Alexander, et al.
Publicado: (2014)

circFAT1 Promotes Cancer Stemness and Immune Evasion by Promoting STAT3 Activation
por: Jia, Lingfei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2a7kbm8u8dr7vauvq5b87gp7nd